Evidence map›Paper›PMID 31356626›Full record

ArticlePloS one2019

Severe cases of seasonal influenza in Russia in 2017-2018.

Natalia P Kolosova, Tatyana N Ilyicheva, Alexey V Danilenko, Julia A Bulanovich, Svetlana V Svyatchenko, Alexander G Durymanov, Natalia I Goncharova, Andrei S Gudymo, Alexander N Shvalov, Ivan M Susloparov and 5 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part I. COVID-19 and Influenza.Molecular genetics, microbiology and virology : Molekulyarnaya genetika, mikrobiologiya i virusologiya · 2022
    Article
  5. Observational
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Natalia P KolosovaState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.ORCID 0000-0001-8865-8592
Tatyana N IlyichevaState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.ORCID 0000-0002-2354-7688
Alexey V DanilenkoState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.
Julia A BulanovichState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.
Svetlana V SvyatchenkoState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.
Alexander G DurymanovState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.
Natalia I GoncharovaState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.
Andrei S GudymoState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.
Alexander N ShvalovState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.
Ivan M SusloparovState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.
Vasiliy Y MarchenkoState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.
Tatyana V TregubchakState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.
Elena V GavrilovaState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.
Rinat A MaksyutovState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.
Alexander B RyzhikovState Research Centre of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk, Russia.
State Research Center of Virology and Biotechnology VECTOR · RUNovosibirsk State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 2017-2018 influenza epidemic season in Russia was characterized by a relatively low morbidity and mortality. We evaluated herd immunity prior to the 2017-2018 influenza season in hemagglutination inhibition assay, and performed characterization of influenza viruses isolated from severe or fatal influenza cases and from influenza cases in people vaccinated in the fall of 2017. During the 2017-2018 epidemic season, 87 influenza A and B viruses were isolated and viruses of the 75 influenza cases, including selected viral isolates and viruses analyzed directly from the original clinical material, were genetically characterized. The analyzed A(H1N1)pdm09 viruses belonged to clade 6B.1, B/Yamagata-like viruses belonged to clade 3, and B/Victoria-like viruses belonged to clade 1A and they were antigenically similar to the corresponding vaccine strains. A(H3N2) viruses belonged to clade 3C.2a and were difficult to characterize antigenically and the analysis indicated antigenic differences from the corresponding egg-grown vaccine strain. The next generation sequencing revealed the presence of D222/G/N polymorphism in the hemagglutinin gene in 32% of the analyzed A(H1N1)pdm09 lethal cases. This study demonstrated the importance of monitoring D222G/N polymorphism, including detection of minor viral variants with the mutations, in the hemagglutinin gene of A(H1N1)pdm09 for epidemiological surveillance. One strain of influenza virus A(H1N1)pdm09 was resistant to oseltamivir and had the H275Y amino acid substitution in the NA protein. All other isolates were susceptible to NA inhibitors. Prior to the 2017-2018 epidemic season, 67.4 million people were vaccinated, which accounted for 46.6% of the country's population. Just before the epidemic season 33-47% and 24-30% of blood sera samples collected within the territory of Russia showed the presence of protective antibody titers against vaccine strains of influenza A and influenza B/Victoria-like, respectively. Mass vaccination of the population had evidently reduced the severity of the flu epidemic during the 2017-2018 influenza epidemic season in Russia.

Indexed as

AdolescentAdultAlphainfluenzavirusChildChild, PreschoolDrug Resistance, ViralEpidemicsEpidemiological MonitoringFemaleHemagglutination Inhibition TestsHemagglutinin Glycoproteins, Influenza VirusHumansInfantInfant, NewbornInfluenza B virusInfluenza, HumanHemagglutinin Glycoproteins, Influenza VirusRNA, Viral

Identifiers

PMID31356626
PMCPMC6663013
OpenAlexW2966077435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.